// App-Quantinova.ai

Sa1049 : THE VIRTUAL ELECTRONIC CHROMOENDOSCOPY (VEC) SCORE IN ULCERATIVE COLITIS EXHIBITS VERY GOOD INTER-RATER AGREEMENT IN SCORING MUCOSAL AND VASCULAR CHANGES AFTER COMPUTERISED MODULE TRAINING: A STUDY ACROSS ACADEMIC AND COMMUNITY PRACTICE.

Researchers

Presenter

  • James Hodson

Principal Investigators

  • Vandana M. Sagar

  • Ashit Shah

  • Naveen Sharma

  • Keith Siau

  • Samuel Smith

  • Stephen Ward

  • Monika M. Widlak

  • Subrata Ghosh

  • Marietta Iacucci

  • Ralph A. Boulton

  • Rachel Cooney

  • Xianyong Gui

  • Tariq Iqbal

  • Ka-Kit Li

  • Saqib Mumtaz

  • Shri Pathmakanthan

  • Mohammed Nabil Quraishi

Medical Centers

  • Department of Pathology and Laboratory Medicine, Calgary Laboratory Services, Calgary, Alberta, Canada

  • Warwick Medical School, Univeristy of Warwick, Coventry, United Kingdom

  • University of Birmingham, Institute of Translational Medicine, Birmingham, United Kingdom

  • Department of Haematology, Leicester Royal Infirmary, Leicester, United Kingdom

  • Department of Colorectal Surgery, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom

  • National Institute of Health Research Birmingham Liver Biomedical Research Unit, University of Birmingham, Birmingham, United Kingdom

  • Department of Gastroenterology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

  • Department of Gastroenterology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

  • Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom

  • University Hospital Birmingham-Queen Elizabeth, Birmingham, United Kingdom

  • Department of Rheumatology, New Cross Hospi- tal, Wolverhampton, United Kingdom

  • Department of Colorectal Surgery, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom

Locations

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • Unknown


Study Design

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim